Clinical Trial Update: Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating perioperative oxaliplatin plus capecitabine for locally advanced gastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: UNKNOWN